Australian Clinical Labs (ACL) Short Interest
Australian Clinical Labs (ASX:ACL) had 5.48% of shares reported as short positions as of 24 Aug 2026, representing 10,216,146 shares. Australian Clinical Labs operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Australian Clinical Labs
Australian Clinical Labs is a leading provider of pathology services in Australia, offering a comprehensive range of diagnostic testing services. The company operates over 50 NATA-accredited laboratories and more than 1,200 collection centers, serving a diverse clientele. Its commitment to quality and innovation positions it as a key player in the healthcare sector.
Short position
Australian Clinical Labs (ASX:ACL) has 5.48% of its shares on issue reported as short positions as of 24 Aug 2026, or about 10,216,146 shares. Over the past 30 days that figure has fallen 1.12 percentage points, and over 90 days it has fallen 2.91 percentage points. Its highest recorded short interest was 10.64% in July 2024. ACL is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ACL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Australian Clinical Labs
About
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss ACL
Start a research thread or post the first pulse update